United Therapeutics Corporation Share Price Today, Forecast Target, Chat & Where To Buy [UTHR]

  • Today's United Therapeutics Corporation share price is 546.04 (as of 10:12 04-Jun-2026) which is a change of -3.43 or 0.13% from the last closing price of 546.04.
  • With 29,351 shares traded this gives United Therapeutics Corporation a market capitalisation of 23,198,834,881.
  • United Therapeutics Corporation's most recent daily high has been 551.9 and daily low 539.76. The United Therapeutics Corporation share price 52 week high has been 609.35 and the 52 week low 272.18.
  • Based on the most recent United Therapeutics Corporation share price opening of 546.04, the current United Therapeutics Corporation EPS (earnings per share) are 27.09 and the PE (price earnings ratio) is 20.15.

Featured Brokers For Buying United Therapeutics Corporation Shares

It currently costs 546.04 to buy one share in United Therapeutics Corporation (as of 10:12 04-Jun-2026) which is a change of -3.43 or 0.13% from the last closing price of 549.47. To buy shares in United Therapeutics Corporation you will need a stock trading platform like City Index.

We have ranked, compared and reviewed some of the best share-dealing platforms and accounts in the UK that are regulated by the Financial Conduct Authority (FCA). The main things to compare when choosing a share dealing account are the costs of buying and selling shares (trading fees) and how much it will cost to keep those shares on your account. You should also compare account types so you have the option to deal shares in a tax-efficient ISA, SIPP or for your children.

Is United Therapeutics Corporation A Good Investment?

The below United Therapeutics Corporation share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold. Subscribe to Good Money Guide Analysis for expert opinion on the latest investment opportunities.

Tell us what you think:

Scroll to Top